Hello JITC Readers,
Welcome to the latest edition of the JITC Digest. It’s August, which means that our Peer Review Mentorship Program is now collecting applications from early career professionals to participate as mentees in the upcoming new class. The first year of the program, currently underway, has been a smashing success, and we’re excited to expand the number of opportunities to help train the next generation of researchers that will keep the field moving forward. You can learn more about the program and how to apply below in the special feature.
For those of you more established in your career, there is less than one month remaining to apply to be the next JITC Editor-in-Chief. If you are an active, well-known and well-regarded scientist, academic, or clinician, I encourage you to consider applying for this inspiring and rewarding position.
As the journal collects applications for these important roles, we also take a look at some of the science being applied across the research spectrum. Kanako Shimuzu and colleagues demonstrate how a therapeutic cancer vaccine combined with CD122-biased IL-2Cx may serve as a promising strategy for patients with advanced cancers. Feifei Wei et al developed a highly accurate, reproducible machine learning-based platform that predicts the immune checkpoint inhibitor response of patients with non-small-cell lung cancer. Check out these featured articles and more in this month’s Digest
Regards,
